December 6, 2017New England Journal of Medicine85 citations

Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer

ADAngela DeMicheleUniversity of Pennsylvania DYDouglas YeeUniversity of Minnesota LELaura J. EssermanUniversity of California, San Francisco

Key Points

Key points are not available for this paper at this time.

Abstract

A study of mouse models of breast cancer suggests that the microenvironment of an established primary breast cancer affects susceptibility to neoadjuvant chemotherapy.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

DeMichele et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7f793a2a48916bbbee82c https://doi.org/https://doi.org/10.1056/nejmcibr1711545

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Timing of Metastasis in Breast Cancer2017 · 71 citations
2Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-272008 · 1,810 citations
370-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer2016 · 2,084 citations
4Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis2014 · 4,798 citations
5Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer2009 · 218 citations

AI से पूछें

Bookmark

View Full Paper